Tafamidis: A Revolutionary Drug for Treating Neurodegenerative and Heart Diseases

Scripps Research scientist Prof. Jeffery Kelly received an unexpected visit from a patient whose life was dramatically improved by tafamidis-a revolutionary drug for treating neurodegenerative and heart diseases, developed by Kelly himself. Kelly is a leading figure at Scripps Research, spearheading efforts to address some of the most pressing medical challenges, including Alzheimer’s and various amyloid diseases. His cutting-edge research on protein misfolding has not only led to the development of tafamidis but has also broadened our understanding of protein aggregation disorders.
Subscribe for more inspiring stories of how Scripps Research scientists are changing lives through groundbreaking science!
www.scripps.edu/